(Q36780750)

English

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.

scientific article published on December 1999

In more languages

Statements

scholarly article

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

James P. Allison

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

E D Kwon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

B A Foster

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A A Hurwitz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Madias

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N M Greenberg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M B Burg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Proceedings of the National Academy of Sciences of the United States of America

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

15074-15079

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

29 September 2017

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

29 September 2017

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

29 September 2017

How tumors become angiogenic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

29 September 2017

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

29 September 2017

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

29 September 2017

Prostate cancer in a transgenic mouse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

29 September 2017

CD28-B7 interactions in T-cell activation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

29 September 2017

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

29 September 2017

The role of CTLA-4 in the regulation and initiation of T-cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

29 September 2017

The emerging role of CTLA-4 as an immune attenuator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

27 June 2018

Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

27 June 2018

Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

27 June 2018

Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

5 September 2018

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

5 September 2018

Dendritic cell maturation and antigen presentation in the absence of invariant chain.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.96.26.15074

21 January 2018

CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24775

20 October 2018

Variable expression of CD3-ζ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: Relationship with til phenotype and function

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.96.26.15074

21 January 2018

Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611340

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611340

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611340

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611340

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611340

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611340

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.96.26.15074

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1999PNAS...9615074K

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611340%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36780750&oldid=1549875119"